UBS Maintains Buy on AdaptHealth, Lowers Price Target to $10
UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $14 to $10.
Stocks · News reference
Crude Oil Down Over 5%; McDonald's Earnings Top Views
U.S. stocks gain with Nasdaq up more than 2% on Tuesday. Dow up 1.79% to 54,129.35, Nasdaq up 2.22% to 26,490.24, S&P 500 up 1.64% to 7,725.48. Tech shares jump 3.8%, utilities down 0.5%. McDonald's beats earnings estimates. Ibotta, Backblaze, Corvex up, Adapthealth, Better Home & Finance, Clearpoint Neuro down.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
RBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $8
RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $15 to $8.
Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $9
Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $14 to $9.
Securities Fraud Investigation Into Better Home & Finance Holding Company (BETR) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz is investigating Better Home & Finance Holding Company for potential federal securities law violations. The company's stock fell 28.5% on May 7, 2026, after missing its $1.0 billion monthly funded loan volume target, and dropped another 36.56% on August 4, 2026, following the abrupt CEO change from founder Vishal Garg to interim CEO Daniel Lewis.
Garg Group Confirms That Better Stockholders Can Vote Their Shares in the Garg Group’s Consent Solicitation with Confidence and Certainty
Vishal Garg, founder and former CEO of Better Home & Finance, confirmed that stockholders can safely vote in his consent solicitation to remove five board directors. Federal courts rejected Better's attempt to halt the solicitation, and Delaware courts confirmed that voting will not trigger the company's poison pill provision. The Garg Group has filed definitive consent solicitation materials with the SEC.
Better Home & Finance Special Committee Calls Former CEO Vishal Garg's Plan 'Utterly Unworkable,' Says He Lacks Lawful Voting Control; Urges Shareholders To Return WHITE Consent Revocation Card